Cardiorespiratory fitness as a vital sign of CVD risk in the COVID-19 era

Matthew P. Harber; James E. Peterman; Mary Imboden; Leonard Kaminsky; Ruth E.M. Ashton; Ross Arena; Mark A. Faghy

doi:10.1016/j.pcad.2022.12.001

Cardiorespiratory fitness as a vital sign of CVD risk in the COVID-19 era

Matthew P. Harber
, James E. Peterman
, Mary Imboden
, Leonard Kaminsky
, Ruth E.M. Ashton
, Ross Arena
, Mark A. Faghy

Research output: Contribution to journal › Article › peer-review

23 Citations (Scopus)

17 Downloads (Pure)

Abstract

The severe health consequences of the corona virus disease 2019 (COVID-19) pandemic have been exacerbated by the prevalence of cardiovascular disease (CVD) risk factors, such as physical inactivity, obesity, hypertension, and diabetes. Further, policy decisions during the pandemic augmented unhealthy lifestyle behaviors and health inequalities, likely increasing the global disease burden. Cardiorespiratory fitness (CRF) is a well-established biomarker associated with CVD risk. Emerging data demonstrate that high CRF offers some protection against severe outcomes from COVID-19 infection, highlighting the importance of CRF for population health and the potential for limiting the severity of future pandemics. CRF is best assessed by cardiopulmonary exercise testing (CPET), which will be an important tool for understanding the prolonged pathophysiology of COVID-19, the emergence of long-COVID, and the lasting effects of COVID-19 on CVD risk. Utilization of CRF and CPET within clinical settings should become commonplace because of lessons learned from the COVID-19 pandemic.

Original language	English
Pages (from-to)	44-48
Number of pages	5
Journal	Progress in Cardiovascular Diseases
Volume	76
Early online date	17 Dec 2022
DOIs	https://doi.org/10.1016/j.pcad.2022.12.001
Publication status	Published - 1 Jan 2023
Externally published	Yes

Bibliographical note

© 2022, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/

Copyright © and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders.

This document is the author’s post-print version, incorporating any revisions agreed during the peer-review process. Some differences between the published version and this version may remain and you are advised to consult the published version if you wish to cite from it.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Cardiopulmonary exercise test
Chronic disease
Functional capacity
Physical activity

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.pcad.2022.12.001

Ashton2022AAMFinal published version, 799 KBLicence: CC BY-NC-ND

Cite this

@article{15dcbab09c6b4c6ca41d21440e899e7c,

title = "Cardiorespiratory fitness as a vital sign of CVD risk in the COVID-19 era",

abstract = "The severe health consequences of the corona virus disease 2019 (COVID-19) pandemic have been exacerbated by the prevalence of cardiovascular disease (CVD) risk factors, such as physical inactivity, obesity, hypertension, and diabetes. Further, policy decisions during the pandemic augmented unhealthy lifestyle behaviors and health inequalities, likely increasing the global disease burden. Cardiorespiratory fitness (CRF) is a well-established biomarker associated with CVD risk. Emerging data demonstrate that high CRF offers some protection against severe outcomes from COVID-19 infection, highlighting the importance of CRF for population health and the potential for limiting the severity of future pandemics. CRF is best assessed by cardiopulmonary exercise testing (CPET), which will be an important tool for understanding the prolonged pathophysiology of COVID-19, the emergence of long-COVID, and the lasting effects of COVID-19 on CVD risk. Utilization of CRF and CPET within clinical settings should become commonplace because of lessons learned from the COVID-19 pandemic.",

keywords = "Cardiopulmonary exercise test, Chronic disease, Functional capacity, Physical activity",

author = "Harber, \{Matthew P.\} and Peterman, \{James E.\} and Mary Imboden and Leonard Kaminsky and Ashton, \{Ruth E.M.\} and Ross Arena and Faghy, \{Mark A.\}",

note = "{\textcopyright} 2022, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ Copyright {\textcopyright} and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders. This document is the author{\textquoteright}s post-print version, incorporating any revisions agreed during the peer-review process. Some differences between the published version and this version may remain and you are advised to consult the published version if you wish to cite from it. ",

year = "2023",

month = jan,

day = "1",

doi = "10.1016/j.pcad.2022.12.001",

language = "English",

volume = "76",

pages = "44--48",

journal = "Progress in Cardiovascular Diseases",

issn = "0033-0620",

publisher = "W.B. Saunders",

}

TY - JOUR

T1 - Cardiorespiratory fitness as a vital sign of CVD risk in the COVID-19 era

AU - Harber, Matthew P.

AU - Peterman, James E.

AU - Imboden, Mary

AU - Kaminsky, Leonard

AU - Ashton, Ruth E.M.

AU - Arena, Ross

AU - Faghy, Mark A.

N1 - © 2022, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ Copyright © and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders. This document is the author’s post-print version, incorporating any revisions agreed during the peer-review process. Some differences between the published version and this version may remain and you are advised to consult the published version if you wish to cite from it.

PY - 2023/1/1

Y1 - 2023/1/1

N2 - The severe health consequences of the corona virus disease 2019 (COVID-19) pandemic have been exacerbated by the prevalence of cardiovascular disease (CVD) risk factors, such as physical inactivity, obesity, hypertension, and diabetes. Further, policy decisions during the pandemic augmented unhealthy lifestyle behaviors and health inequalities, likely increasing the global disease burden. Cardiorespiratory fitness (CRF) is a well-established biomarker associated with CVD risk. Emerging data demonstrate that high CRF offers some protection against severe outcomes from COVID-19 infection, highlighting the importance of CRF for population health and the potential for limiting the severity of future pandemics. CRF is best assessed by cardiopulmonary exercise testing (CPET), which will be an important tool for understanding the prolonged pathophysiology of COVID-19, the emergence of long-COVID, and the lasting effects of COVID-19 on CVD risk. Utilization of CRF and CPET within clinical settings should become commonplace because of lessons learned from the COVID-19 pandemic.

AB - The severe health consequences of the corona virus disease 2019 (COVID-19) pandemic have been exacerbated by the prevalence of cardiovascular disease (CVD) risk factors, such as physical inactivity, obesity, hypertension, and diabetes. Further, policy decisions during the pandemic augmented unhealthy lifestyle behaviors and health inequalities, likely increasing the global disease burden. Cardiorespiratory fitness (CRF) is a well-established biomarker associated with CVD risk. Emerging data demonstrate that high CRF offers some protection against severe outcomes from COVID-19 infection, highlighting the importance of CRF for population health and the potential for limiting the severity of future pandemics. CRF is best assessed by cardiopulmonary exercise testing (CPET), which will be an important tool for understanding the prolonged pathophysiology of COVID-19, the emergence of long-COVID, and the lasting effects of COVID-19 on CVD risk. Utilization of CRF and CPET within clinical settings should become commonplace because of lessons learned from the COVID-19 pandemic.

KW - Cardiopulmonary exercise test

KW - Chronic disease

KW - Functional capacity

KW - Physical activity

UR - http://dx.doi.org/10.1016/j.pcad.2022.12.001

UR - https://www.scopus.com/pages/publications/85146013158

U2 - 10.1016/j.pcad.2022.12.001

DO - 10.1016/j.pcad.2022.12.001

M3 - Article

SN - 0033-0620

VL - 76

SP - 44

EP - 48

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

ER -

Cardiorespiratory fitness as a vital sign of CVD risk in the COVID-19 era

Abstract

Bibliographical note

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this